Metabolomics and medical practice;Metabolomica e pratica medica

Clinica Terapeutica

Volumn 157, Issue 6, 2006, Pages 549-552

  Conti, F ^a   Manganaro, M ^a,b   Miccheli, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Drugs; Heart; Kidney; Liver; Metabolomics; Transplants

Indexed keywords

DNA MODIFICATION; MEDICAL PRACTICE; METABOLISM; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW;

DRUG MONITORING; DRUG TOXICITY; HUMANS; KIDNEY; LIVER; METABOLISM; MONITORING, PHYSIOLOGIC; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; ORGAN TRANSPLANTATION;

EID: 33845946565     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Wishart DS, Querengesser LMM, Lefebvre BA, et al.: Magnetic Resonance Diagnostics: A New Technology for High-Throughput Clinical Diagnostics. Clin Chem 2001; 147:1918-21
2. Nicholson JK, Lindon JC, Holmes E: Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181-9
3. 1H-NMR studies of vertebrate blood and plasma. Biochem J 1983; 211:601-15
4. Nicholson JK, O'Flynn MP, Sadler JP, et al.: High resolution proton NMR spectroscopic studies on plasma and urine from diabetic and fasting normal subjects. Biochem J 1984; 217: 365-75
5. Bales JR, Higham DP, Howe I, et al.: Use of High-Resolution Proton Nuclear Magnetic Resonance Spectroscopy for Rapid Multi-Component Analysis of Urine. Clin Chem 1984; 30:426-32
6. 1H Nuclear Magnetic Resonance Spectra of Urine from Normal and Pathological States. Annal Biochem 1994; 220:284-96
7. 1H-NMR-based metabonomics. Nature Med 2002; 8:1439-44
8. 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed 1984; 11:335-44
9. Lindon JC, Holmes E, Bollard ME, et al.: REVIEW Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 2004; 9:1-31
10. Robertson DG, Reily MD, Sigler RE, et al.: Metabonomics: Evaluation of Nuclear Magnetic Resonance (NMR) and Pattern Recognition Technology for Rapid in vivo Screening of Liver and Kidney Toxicants. Toxicol Sci 2000; 57:326-37
11. Foxall PJD, Mellotte GJ, Bending MR, et al.: NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int 1993; 43:234-45
12. Le Moyek L, Pruna A, Eugène M, et al.: Proton Nuclear Magnetic Resonance Spectros copy of Urine and Plasma in Renal Transplantation Follow-up. Nephron 1993; 65:433-9
13. Hauet T, Baumert H, Gibelin H, et al.: Noninvasive Monitoring of Citrate, Acetate, Lactate, and Renal Medullary Osmolate Excretion in Urine as Biomarkers of Exposure to Ischemic Reperfusion Injury. Cryobiology 2000; 41:280-91
14. Wishart DS: Metabolomics: the principles and potential applications to transplantation. Am J Transpl 2005; 5:2814-20
15. Gibelin H, Eugene M, Hebrard W, et al.: A New Approach to Evaluation of Liver Graft Function by Nuclear Magnetic Resonance Spectroscopy. A Comparative Study between Euro-Collins and University of Wisconsin Solutions. Clin Chem Lab Med 2000; 38:1133-6
16. Melendez HV, Ahmadi D, Parkes HG, et al.: Proton Nuclear Magnetic Resonance analysis of Hepatic Bile from Donors and Recipients in Human Liver Transplantation. Transplant 2001; 72:855-60
17. 1H-NMR spectroscopy in assessment of liver graft dysfunction. NMR Biomed 2003; 16:185-8
18. Eugene M, Le Moyec L, De Certaines J, et al.: Lipoproteins in Heart Transplantation: Proton Magnetic Resonance Spectroscopy of Plasma. Magn Res Med 1991; 18:93-101
19. Mouly-Bandini A, Vion-Dury J, Viout P, et al.: Detection of acute rejection by high resolution proton magnetic resonance spectroscopy of plasma. MAGMA 2000; 11:27-32
20. Subramanian A, Gupta A, Saxena S, et al.: Proton MR CSF analysis and new software as Predictors for the differentiation of meningitis in children. NMR Biomed 2005; 18:213-225